Ergoteles LLC Omeros Corp Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.92 - $6.28 $339,141 - $1.11 Million	176,636 Added 1024.1%	193,884 $533,000
Q1 2022 May 13, 2022	SELL	$5.07 - $7.2 $89,409 - $126,972	-17,635 Reduced 50.55%	17,248 $104,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $5,670 - $8,540	-1,000 Reduced 2.79%	34,883 $224,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $480,832 - $584,892	35,883 New	35,883 $495,000

121

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $555M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.